185 related articles for article (PubMed ID: 29626002)
1. Evaluating off-label uses of acetazolamide.
Van Berkel MA; Elefritz JL
Am J Health Syst Pharm; 2018 Apr; 75(8):524-531. PubMed ID: 29626002
[TBL] [Abstract][Full Text] [Related]
2. Acetazolamide for high intracranial pressure cerebrospinal fluid leaks.
Chaaban MR; Illing E; Riley KO; Woodworth BA
Int Forum Allergy Rhinol; 2013 Sep; 3(9):718-21. PubMed ID: 23733323
[TBL] [Abstract][Full Text] [Related]
3. Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
Faisy C; Meziani F; Planquette B; Clavel M; Gacouin A; Bornstain C; Schneider F; Duguet A; Gibot S; Lerolle N; Ricard JD; Sanchez O; Djibre M; Ricome JL; Rabbat A; Heming N; Urien S; Esvan M; Katsahian S;
JAMA; 2016 Feb; 315(5):480-8. PubMed ID: 26836730
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation.
Yano I; Takayama A; Takano M; Inatani M; Tanihara H; Ogura Y; Honda Y; Inui K
Eur J Clin Pharmacol; 1998 Mar; 54(1):63-8. PubMed ID: 9591933
[TBL] [Abstract][Full Text] [Related]
5. Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice.
Gulati S; Aref AA
Expert Rev Clin Pharmacol; 2021 Aug; 14(8):955-961. PubMed ID: 34003717
[No Abstract] [Full Text] [Related]
6. CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
Kattah JC; Pula JH; Mejico LJ; McDermott MP; Kupersmith MJ; Wall M
J Neurol; 2015 Oct; 262(10):2271-4. PubMed ID: 26159101
[TBL] [Abstract][Full Text] [Related]
7. Promising complexes of acetazolamide for topical ocular administration.
Granero GE; Longhi MR
Expert Opin Drug Deliv; 2010 Aug; 7(8):943-53. PubMed ID: 20565335
[TBL] [Abstract][Full Text] [Related]
8. A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials.
Hampson AJ; Babalonis S; Lofwall MR; Nuzzo PA; Krieter P; Walsh SL
J Clin Psychopharmacol; 2016 Aug; 36(4):324-32. PubMed ID: 27300254
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation.
Faisy C; Mokline A; Sanchez O; Tadié JM; Fagon JY
Intensive Care Med; 2010 May; 36(5):859-63. PubMed ID: 20217045
[TBL] [Abstract][Full Text] [Related]
10. Acetazolamide for the treatment of idiopathic intracranial hypertension.
Supuran CT
Expert Rev Neurother; 2015; 15(8):851-6. PubMed ID: 26154918
[TBL] [Abstract][Full Text] [Related]
11. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness.
Leshem E; Caine Y; Rosenberg E; Maaravi Y; Hermesh H; Schwartz E
J Travel Med; 2012; 19(5):308-10. PubMed ID: 22943271
[TBL] [Abstract][Full Text] [Related]
12. Acetazolamide Mitigates Intracranial Pressure Spikes Without Affecting Functional Outcome After Experimental Hemorrhagic Stroke.
Williamson MR; Wilkinson CM; Dietrich K; Colbourne F
Transl Stroke Res; 2019 Aug; 10(4):428-439. PubMed ID: 30225552
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.
Leaf DE; Goldfarb DS
J Appl Physiol (1985); 2007 Apr; 102(4):1313-22. PubMed ID: 17023566
[TBL] [Abstract][Full Text] [Related]
14. Internephron heterogeneity for carbonic anhydrase-independent bicarbonate reabsorption in the rat.
Frommer JP; Laski ME; Wesson DE; Kurtzman NA
J Clin Invest; 1984 Apr; 73(4):1034-45. PubMed ID: 6423664
[TBL] [Abstract][Full Text] [Related]
15. Cerebral oxygenation in patients with OSA: effects of hypoxia at altitude and impact of acetazolamide.
Ulrich S; Nussbaumer-Ochsner Y; Vasic I; Hasler E; Latshang TD; Kohler M; Muehlemann T; Wolf M; Bloch KE
Chest; 2014 Aug; 146(2):299-308. PubMed ID: 24811331
[TBL] [Abstract][Full Text] [Related]
16. Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: a randomized, double-blind trial.
Mazur JE; Devlin JW; Peters MJ; Jankowski MA; Iannuzzi MC; Zarowitz BJ
Crit Care Med; 1999 Jul; 27(7):1257-61. PubMed ID: 10446816
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude.
Ritschel WA; Paulos C; Arancibia A; Agrawal MA; Wetzelsberger KM; Lücker PW
Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):133-7. PubMed ID: 9604855
[TBL] [Abstract][Full Text] [Related]
18. Effect of MK-507 on aqueous humor dynamics in normal human eyes.
Yamazaki Y; Miyamoto S; Sawa M
Jpn J Ophthalmol; 1994; 38(1):92-6. PubMed ID: 7933704
[TBL] [Abstract][Full Text] [Related]
19. Acetazolamide in critically ill neonates and children with metabolic alkalosis.
Andrews MG; Johnson PN; Lammers EM; Harrison DL; Miller JL
Ann Pharmacother; 2013 Sep; 47(9):1130-5. PubMed ID: 24259727
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients.
Heming N; Faisy C; Urien S
Crit Care; 2011; 15(5):R213. PubMed ID: 21917139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
